Blood group isoantigen and involucrin expression in cervical intraepithelial neoplasia.
258 patients with dysplastic cervical lesions reclassified as CIN 1-3 and AIM 1-3 and with up to ten years of follow-up were immunostained with monoclonal antibodies against blood group isoantigens and involucrin for expression in normal and dysplastic squamous epithelium. The results show a varied staining pattern with a majority of unchanged staining properties in normal and dysplastic epithelium, the same frequency of increase as decrease in dysplasia and no correlation to progression or recurrence, in variance with previous reports.
D000017:ABO Blood-Group System / Q000276:immunology*; D000328:Adult; D002278:Carcinoma in Situ / Q000276:immunology / Q000473:pathology; D004848:Epithelium / Q000276:immunology; D005260:Female; D006801:Humans; D007519:Isoantigens / Q000032:analysis; D008875:Middle Aged; D011498:Protein Precursors / Q000032:analysis*; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000473:pathology*
D000017:ABO Blood-Group System; D007519:Isoantigens; D011498:Protein Precursors; C032253:involucrin